IGGQ Research Publishing
Clinical Translation & Population Health
Review Article Published August 27, 2026 Article ct20260007

Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells: Robustness Under Distribution Shift

Read & download PDF
Abstract

Robustness depends on whether conclusions remain stable when the data distribution, case mix, prevalence, or operating environment differs from the reported setting. This structured evidence review evaluates "Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells" alongside nine author-disjoint, topically matched publications in molecular expression profiling. It compares construct definitions, evaluation choices, operating assumptions, and reported limitations instead of treating bibliographic similarity as empirical equivalence. Viewed through robustness under distribution shift, the map separates claims supported by the available record from questions that still require full-text extraction, replication, or new experiments. The synthesis is interpretive rather than meta-analytic and therefore does not present a pooled effect estimate or a new causal result. The resulting agenda uses prespecified shift scenarios, subgroup analysis, calibration checks, and post-deployment monitoring to locate failure boundaries.

Keywords
molecular expression profilingrobustness under distribution shiftevidence synthesisreproducibilityresearch evaluation
References
  1. Dai, R., Tao, R., Li, X., Shang, T., Zhao, S., & Ren, Q. (2022). Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells. Frontiers in Microbiology, 13, 979087. https://doi.org/10.3389/fmicb.2022.979087 DOI
  2. Hosseinipour, M., Wan, F., Altomare, D., Creek, K.-E., & Pirisi, L. (2019). HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression. Virology, 537, 20-30. https://doi.org/10.1016/j.virol.2019.08.009 DOI
  3. Diaz, D. (2012). HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. International Journal of Oncology. https://doi.org/10.3892/ijo.2012.1429 DOI
  4. Benedetti, I., Barrios, L., & Reyes, N. (2018). Abstract 1489: Differential gene expression profiles between normal cervical tissue and high-grade squamous intraepithelial lesion expressing p16 and high-risk HPV E6/E7 mRNA. Cancer Research, 78(13_Supplement), 1489-1489. https://doi.org/10.1158/1538-7445.am2018-1489 DOI
  5. Zhang, J., Li, S., Yan, Q., Chen, X., Yang, Y., Liu, X., & Wan, X. (2013). Interferon-β Induced microRNA-129-5p Down-Regulates HPV-18 E6 and E7 Viral Gene Expression by Targeting SP1 in Cervical Cancer Cells. PLoS ONE, 8(12), e81366. https://doi.org/10.1371/journal.pone.0081366 DOI
  6. Riethdorf, S., Riethdorf, L., Milde-Langosch, K., Park, T.-W., & Löning, T. (2000). Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Archiv, 437(5), 491-500. https://doi.org/10.1007/s004280000277 DOI
  7. Zhang, L., Li, M., Yuan, F., Jiang, J., & Zhang, X. (2024). The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16. Medicine, 103(3), e36822. https://doi.org/10.1097/md.0000000000036822 DOI
  8. Finzer, P., Ventz, R., Kuntzen, C., Seibert, N., Soto, U., & Rösl, F. (2002). Growth Arrest of HPV-Positive Cells after Histone Deacetylase Inhibition Is Independent of E6/E7 Oncogene Expression. Virology, 304(2), 265-273. https://doi.org/10.1006/viro.2002.1667 DOI
  9. Lee, C.-J., Suh, E.-J., Kang, H.-T., Im, J.-S., Um, S.-J., Park, J.-S., & Hwang, E.-S. (2002). Induction of Senescence-like State and Suppression of Telomerase Activity through Inhibition of HPV E6/E7 Gene Expression in Cells Immortalized by HPV16 DNA. Experimental Cell Research, 277(2), 173-182. https://doi.org/10.1006/excr.2002.5554 DOI
  10. Stich, M., Ganss, L., Puschhof, J., Prigge, E.-S., Reuschenbach, M., Guiterrez, A., Vinokurova, S., & von Knebel Doeberitz, M. (2017). 5-aza-2′-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells. Oncotarget, 8(32), 52104-52117. https://doi.org/10.18632/oncotarget.10631 DOI
Publication details
Journal
Clinical Translation & Population Health
Volume
1 (2026)
Article number
ct20260007
License
CC BY 4.0